» Articles » PMID: 11134615

Neurochemical Changes and Laser Doppler Flowmetry in the Endothelin-1 Rat Model for Focal Cerebral Ischemia

Overview
Journal Brain Res
Specialty Neurology
Date 2001 Jan 3
PMID 11134615
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Generalized neurotransmitter overflow into the extracellular space, after cerebral ischemia, has been suggested to contribute to subsequent neuronal death. This study aims to investigate the striatal release of the neurotransmitters dopamine (DA), glutamate (Glu) and gamma-aminobutyric acid (GABA) by means of microdialysis, in a rat model for focal transient cerebral ischemia. Ischemia was induced by the application of 120 pmol endothelin-1 (Et-1), adjacent to the middle cerebral artery (MCA) in freely moving rats. Ischemia produced a large increase in extracellular striatal DA concentrations (2400%), Glu (5500%) and GABA (800%) concentrations. Laser Doppler flowmetry in anaesthetized rats, indicated that the blood flow within the striatum decreased by 75+/-11%. The period of sustained drop of blood flow, was dose-dependently related to the concentration Et-1 injected. Histological analysis of brain slices, taken from anaesthetized and conscious animals, indicated a 500 pmol dose of Et-1 was required to produce a similar infarct in anaesthetized rats to a 120 pmol dose of Et-1 in freely moving rats. The immediate drop in striatal blood flow, and the prompt increase of extracellular DA, after the micro-application of Et-1, were quite striking. This suggests that the DA release, rather than the Glu overflow may be the primary event initiating the cascade of processes ultimately leading to cell death and neurological deficits.

Citing Articles

New approach to control ischemic severity ex vivo.

Modi B, Caldwell K, Witt C, Weese-Myers M, Ross A J Neurosci Methods. 2024; 413:110321.

PMID: 39532187 PMC: 11627121. DOI: 10.1016/j.jneumeth.2024.110321.


Group III metabotropic glutamate receptors: guardians against excitotoxicity in ischemic brain injury, with implications for neonatal contexts.

Mielecki D, Salinska E Pharmacol Rep. 2024; 76(6):1199-1218.

PMID: 39298028 PMC: 11582219. DOI: 10.1007/s43440-024-00651-z.


Metabotropic glutamate receptors-guardians and gatekeepers in neonatal hypoxic-ischemic brain injury.

Mielecki D, Bratek-Gerej E, Salinska E Pharmacol Rep. 2024; 76(6):1272-1285.

PMID: 39289333 PMC: 11582255. DOI: 10.1007/s43440-024-00653-x.


Animal models of stroke.

Li Y, Zhang J Animal Model Exp Med. 2021; 4(3):204-219.

PMID: 34557647 PMC: 8446711. DOI: 10.1002/ame2.12179.


Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.

Crigna A, Link B, Samec M, Giordano F, Kubatka P, Golubnitschaja O EPMA J. 2021; 12(3):265-305.

PMID: 34367381 PMC: 8334338. DOI: 10.1007/s13167-021-00248-z.